​THE RPCVD

REVOLUTION

Welcome to BluGlass. We are an Australian clean technology company that is developing and commercialising a breakthrough semiconductor technology called remote plasma chemical vapour deposition (RPCVD), for the production of high efficiency devices such as light emitting diodes (LEDs), laser diodes and power electronics.

RPCVD has several potential advantages over current manufacturing techniques promising higher performing devices and a cleaner, lower temperature and lower cost method of manufacture.

RPCVD has several potential advantages over current manufacturing techniques for LEDs, microLEDs and cascade LEDs to produce higher performing and lower cost devices.

RPCVD's unique tunnel junction capability offers laser diode manufacturers a number of performance and cost advantages over the industry incumbent (MOCVD) technology.

BluGlass's service arm, EpiBlu Pty Ltd offers highly specialised expitaxial  and characterisation services at its state-of-the-art laboratory operated by experienced technical staff in Sydney, Australia.

COMPOUND SEMICONDUCTOR FEATURE  - HYBRID GROWTH (RPCVD & MOCVD) PROMISES BETTER LASER DIODE PERFORMANCE

How adding 'active-as-grown' tunnel junctions by remote plasma chemical vapour deposition (RPCVD) can lead to more-powerful, more-efficient GaN lasers.

INDEPENDENT EXPERT REPORT - ASSESSMENT OF BLUGLASS' RPCVD TECHNOLOGY

BluGlass is pleased to provide an independent expert review of the RPCVD Technology by technical consultant, Dr Dominique Morrison (BSc(Hons) MSc PhD).

 

The report provides a

- clear analysis of the benefits of BluGlass' key technologies/IP assets

- presents a benefit comparison of RPCVD, relative to the incumbent MOCVD technology (advantages and disadvantages) for each of the identified applications

- identifies potential barriers to commercialisation

- identifies key LED and Laser Diode players

- provides an assessment of the deliverability/manufacturability of the technology and summarises the current status

- identifies what is needed for effective deployment into the end markets

 

The report is available to download here

 

Dr Morrison specialises in the assessment of innovative and potentially disruptive technologies. As a contracted expert, Dr Morrison supports the evaluation of innovation actions for both the European Commission and the UK’s innovation agency (Innovate UK).

PATH TO COMMERCIAL REVENUES - INVESTOR UPDATE, MARCH 2020
Features:
  • Laser Diode Business Update
     

  • End Market Growth and Drivers
     

  • Economic Scenarios and Target Revenues to 2025
     

  • Cascade and microLED Update
     

  • Commercial Partnerships

VIDEO - BLUGLASS UPDATE: 

Managing Director, Giles Bourne sits down with Rachael Jones from Finance News Network to discuss the company's 1:1 non-renounceable rights issue, the need to fund its technology through to commercialisation, the independent expert analysis of its RPCVD technology and its response to COVID-19.

SPIE PHOTONICS WEST 2020
SAN FRANCISCO, USA

SPIE, the international society for optics and photonics Photonics West wrap-up:

Considerable interest from the industry in how we can deploy #RPCVD in the fabrication of tunnel junctions for #laserdiodes.

 

Our paper presented by Dr. Josh Brown on how hybrid growth (RPCVD and MOCVD) can enable novel LD structures and improve laser diode performance was also well-received. #tunneljunctions #laserdiodes #photonicswest #optics

1/5

LATEST NEWS

INVESTOR INFO

CONTACT US

ASX  :   BLG

BluGlass is an Australian public company listed on the Australian Stock Exchange to bring to market a breakthrough in the semiconductor technology industry.

Please reload

INVESTOR MAIL

74 Asquith Street

Silverwater, NSW, 2128
Australia

P: +61 2 9334 2300

FOLLOW US
  • LinkedIn Social Icon
  • Twitter Social Icon